Neuronetics

-$0.06 (-1.87%) As of 5:51 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Neuronetics and other ETFs, options, and stocks.

About STIM

Neuronetics, Inc. commercial stage medical technology company, which engages in the designing, developing and marketing products for the patients suffering from psychiatric disorders. It operates through United States and International geographical segments.

CEO

Keith J. Sullivan

Employees

175

Headquarters

Malvern, Pennsylvania

Founded

2001

STIM Key Statistics

Market cap

Price-Earnings ratio

—

Dividend yield

—

Average volume

432.00K

High today

$3.34

Low today

$3.13

Open price

$3.22

Volume

62.46K

52 Week high

$16.25

52 Week low

$1.98

STIM News

Barron'sJun 24

Neuronetics, New Relic Stocks See Action From Activist Investors

Text size These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10 days of an entity’s attaining more than 5

STIM Earnings

-$0.41

-$0.27

-$0.14

$0.00

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Estimated

— per share

Actual

Expected Aug 4, Pre-Market

Why Robinhood?

Neuronetics, Inc. commercial stage medical technology company, which engages in the designing, developing and marketing products for the patients suffering from psychiatric disorders. It operates through United States and International geographical segments. View more

Neuronetics, New Relic Stocks See Action From Activist Investors

Neuronetics, Inc. commercial stage medical technology company, which engages in the designing, developing and marketing products for the patients suffering from psychiatric disorders. It operates through United States and International geographical segments.